Verde Bio Holdings Stock Performance
| APHD Stock | USD 0.75 0.05 6.25% |
Verde Bio holds a performance score of 9 on a scale of zero to a hundred. The entity has a beta of 95.0, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Verde Bio will likely underperform. Use Verde Bio Holdings semi variance, day typical price, and the relationship between the value at risk and kurtosis , to analyze future returns on Verde Bio Holdings.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Verde Bio Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical indicators, Verde Bio exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Verde |
Verde Bio Relative Risk vs. Return Landscape
If you would invest 100.00 in Verde Bio Holdings on October 29, 2025 and sell it today you would lose (25.00) from holding Verde Bio Holdings or give up 25.0% of portfolio value over 90 days. Verde Bio Holdings is currently generating 15.779% in daily expected returns and assumes 129.9082% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Verde, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Verde Bio Target Price Odds to finish over Current Price
The tendency of Verde Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.75 | 90 days | 0.75 | about 57.26 |
Based on a normal probability distribution, the odds of Verde Bio to move above the current price in 90 days from now is about 57.26 (This Verde Bio Holdings probability density function shows the probability of Verde Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 95.0 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Verde Bio will likely underperform. In addition to that Verde Bio Holdings has an alpha of 77.5943, implying that it can generate a 77.59 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Verde Bio Price Density |
| Price |
Predictive Modules for Verde Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Verde Bio Holdings. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Verde Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Verde Bio is not an exception. The market had few large corrections towards the Verde Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Verde Bio Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Verde Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 77.59 | |
β | Beta against Dow Jones | 95.00 | |
σ | Overall volatility | 0.71 | |
Ir | Information ratio | 0.17 |
Verde Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Verde Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Verde Bio Holdings can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Verde Bio Holdings is way too risky over 90 days horizon | |
| Verde Bio Holdings has some characteristics of a very speculative penny stock | |
| Verde Bio Holdings appears to be risky and price may revert if volatility continues | |
| Verde Bio Holdings currently holds 1.07 M in liabilities. Verde Bio Holdings has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Verde Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Verde Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Verde Bio Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Verde to invest in growth at high rates of return. When we think about Verde Bio's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 456.04 K. Net Loss for the year was (1.58 M) with profit before overhead, payroll, taxes, and interest of 11.54 K. | |
| Verde Bio Holdings currently holds about 126.02 K in cash with (177.75 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5. |
Verde Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Verde Pink Sheet often depends not only on the future outlook of the current and potential Verde Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Verde Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.5 M | |
| Cash And Short Term Investments | 1631.00 |
Verde Bio Fundamentals Growth
Verde Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Verde Bio, and Verde Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Verde Pink Sheet performance.
| Return On Asset | -0.16 | |||
| Operating Margin | (0.99) % | |||
| Current Valuation | 286.8 K | |||
| Shares Outstanding | 254.04 K | |||
| Price To Earning | (0.20) X | |||
| Price To Sales | 0.94 X | |||
| Revenue | 456.04 K | |||
| EBITDA | (1.27 M) | |||
| Cash And Equivalents | 126.02 K | |||
| Cash Per Share | 0.50 X | |||
| Total Debt | 1.07 M | |||
| Book Value Per Share | (5.54) X | |||
| Cash Flow From Operations | (177.75 K) | |||
| Earnings Per Share | (1.26) X | |||
| Total Asset | 1.63 K | |||
| Retained Earnings | (2.43 M) | |||
| Current Asset | 28 K | |||
| Current Liabilities | 986 K | |||
About Verde Bio Performance
By analyzing Verde Bio's fundamental ratios, stakeholders can gain valuable insights into Verde Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Verde Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Verde Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
The company primarily provides MagCast Publishing Platform, a cloud-based digital publishing software which enables customers to create mobile magazine apps, as well as facilitates the monetization of digital content through advanced marketing functions. Apogee 21 Holdings, Inc. was founded in 2005 and is based in Wheat Ridge, Colorado. Apogee 21 operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 11 people.Things to note about Verde Bio Holdings performance evaluation
Checking the ongoing alerts about Verde Bio for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Verde Bio Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Verde Bio Holdings is way too risky over 90 days horizon | |
| Verde Bio Holdings has some characteristics of a very speculative penny stock | |
| Verde Bio Holdings appears to be risky and price may revert if volatility continues | |
| Verde Bio Holdings currently holds 1.07 M in liabilities. Verde Bio Holdings has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Verde Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Verde Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Verde Bio Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Verde to invest in growth at high rates of return. When we think about Verde Bio's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 456.04 K. Net Loss for the year was (1.58 M) with profit before overhead, payroll, taxes, and interest of 11.54 K. | |
| Verde Bio Holdings currently holds about 126.02 K in cash with (177.75 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5. |
- Analyzing Verde Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Verde Bio's stock is overvalued or undervalued compared to its peers.
- Examining Verde Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Verde Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Verde Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Verde Bio's pink sheet. These opinions can provide insight into Verde Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Verde Pink Sheet analysis
When running Verde Bio's price analysis, check to measure Verde Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verde Bio is operating at the current time. Most of Verde Bio's value examination focuses on studying past and present price action to predict the probability of Verde Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verde Bio's price. Additionally, you may evaluate how the addition of Verde Bio to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |